Notably, its strong prognostic significance coupled with effect of its downregulation on the cancer cell hallmarks in KIRC cell lines, indicate that SCAT5 could be a potential therapeutic target in the treatment of kidney cancers. The gene discussed is LUCAT1; the disease is kidney cancer.